(Reuters) Tova Cohen - Alpha Tau Medical, an Israeli developer of alpha radiation cancer therapy, said on Wednesday it raised $29 million in a private financing round. The company said its technology delivers high-precision alpha radiation that is released when radioactive substances decay inside the tumor. The short-range alpha particles kill cancer cells while sparing surrounding healthy tissue. Preliminary clinical results showed the patients' tumor sizes reducing and more than 70% completely disappearing within a few days after treatment.
2018-09-07 00:00:00Full ArticleBACK Visit the Daily Alert Archive